ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
ACT NOW – Cancer Trials At The Leading Edge
A thought leadership article by Martin Lachs, Olivier Saulin and Chris Learn on how CROs can best support increasing demand for ACT clinical trials.
Icon non-executive chairman awarded RDS gold medal for outstanding leadership
An article featuring commentary from Ciarán Murray on his achievement of being awarded with the RDS gold medal for enterprise for outstanding leadership.
Ciarán Murray – an Icon of leadership in pharma sector
An article featuring commentary from Ciarán Murray on the growth of ICON and his career journey to achieve the RDS Gold Medal for Industry.
Oncology Clinical Trials in APAC
Clinical research in APAC and some of the factors affecting it, particularly in oncology
Key Considerations for Disease Modifying Parkinson's Disease Trials
Key considerations for disease modifying parkinson's disease trials
How to use digital health in clinical trials to improve patient engagement
A thought leadership article discussing the positive outcomes of a unified patient experience.
Precision medicine: Overcoming cost challenges
Learn how the solutions are two-fold; requiring implementation of technologies to enhance treatment efficacy, coupled with the optimisation of value-based models.
New Unfoldings in Pharma Compliance
Discover strategies to navigate upcoming disruptions and highlighting best practice to ensure compliance for digital clinical trials in this media article.
Improving Pharma R&D Efficiency
This article explores the need for a holistic and integrated approach to improve clinical trial efficiencies.
Hybrid Study Designs & the Link Between RWE, Epidemiology
Read how hybrid study designs can be advantageous for the generation of RWE, providing a potential solution to the challenges presented by observational studies.